Trametinib
Overview
Trametinib is a kinase inhibitor used for the treatment of melanoma, specifically targeting MEK1 and MEK2. It is often used in combination with other medications to treat unresectable or metastatic melanoma with a mutation in the BRAF gene.
API suppliers (3)
Suppliers of Trametinib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
3 of 3 hold a GMP certificate on record in the EU or UK registers
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
- Zhejiang Ausun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
Therapeutic areas
Do you supply Trametinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.